PTX3 and cardiovascular disorder: PTX3, a member of the pentraxin superfamily of acute phase proteins, is considered to be a novel immunoinflammatory marker that has been reported to associate with cardiometabolic risk factors and to predict adverse outcomes in individuals with cardiovascular disease [30].